Search

Sep 10, 2024
The Co-CEOs of Summit Therapeutics discuss the ivonescimab vs Keytruda data that was presented at the 2024 World Conference on Lung Cancer
Bob Duggan and Maky Zanganeh answer questions relating to China derived data, designing U.S. studies, how to scale the development of the...

Jun 1, 2024
Summit Therapeutics' Jack West on the company's PD-1xVEGF bi-specific vs Keytruda news
V.P. of Clinical Operations Jack West gives his interpretation of the announcement that Summit's partner Akeso made in China that it beat...